Mesoblast Limited (MEOBF) Financials
MEOBF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | ? | ? |
| Dec. 31, 2025 | 782.3 million | 207.6 million |
| Sept. 30, 2025 | ? | ? |
| June 30, 2025 | 784.7 million | 187.2 million |
MEOBF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -4.5 million | ? |
| Dec. 31, 2025 | -15.7 million | ? |
| Sept. 30, 2025 | -15.3 million | ? |
| June 30, 2025 | -17.1 million | ? |
MEOBF Net Income
No data available :(
MEOBF Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | - | - | - |
| Dec. 31, 2025 | 129.6 million | 60.1 million | 8.3 million |
| Sept. 30, 2025 | - | - | - |
| June 30, 2025 | 161.2 million | 67.7 million | 6.3 million |
MEOBF Shares Outstanding
MEOBF Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | 352000 | - | - | - |
| Dec. 31, 2025 | 133000 | - | - | - |
| Sept. 30, 2025 | 349000 | - | - | - |
| June 30, 2025 | 499000 | 7.1 million | 11.1 million | 2.5 million |
MEOBF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | - | - |
| Dec. 31, 2025 | - | - |
| Sept. 30, 2025 | - | - |
| June 30, 2025 | 7.0 million | 23.2 million |
MEOBF
Price: $1.55
52 week price:
Earnings Per Share: -0.07 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 2.2 billion